Michael R. Eber, BSE
Advertisement
Articles by Michael R. Eber, BSE
Advertisement
Latest Updated Articles
- Measuring the Value of Better Diabetes Management
April 12th 2013
Advertisement
Advertisement
Trending on AJMC
1
5 August FDA Approvals Marked by Novelty, Pushback
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5